← All funded startups

October 23, 2026

Hexagon Bio

Biotech company developing novel antibody-drug conjugates and cancer therapeutics.

Round: Series C
Amount raised: $62M
Lead investor: —
Industry: Biotechnology
Headquarters: Menlo Park
Employees: —
Website: —
LinkedIn: —